Trials / Unknown
UnknownNCT00319293
Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Aarhus University Hospital Skejby · Academic / Other
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
Insulin resistance is an important feature of the polycystic ovary syndrome,and patiens are successfully treated with the insulin sensitizing agent metformin. The insulin resistance of lean patients with the syndrome is debated. In this study, we will study the change in insulin resistance, metabolic and hormonal factors after 3 months of metformin treatment in lean PCOS women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin |
Timeline
- First posted
- 2006-04-27
- Last updated
- 2006-10-11
Source: ClinicalTrials.gov record NCT00319293. Inclusion in this directory is not an endorsement.